Who
Douglas Kirk Ways
Interim Chief Medical Officer
Company insider
Files Form 4 as: Interim Chief Medical Officer, Spruce Biosciences.
In numbers
- Trades disclosed
- 19
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 23 Jun 2021
- Last trade
- 11 Dec 2025
- Last filed
- 21 Jan 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 11 Dec 2025filed 21 Jan 2026 | SPRB Spruce BiosciencesBiotechnology | SEC FORM 4 Code M | —1,250 at $0.00 | filing |
| 11 Dec 2025filed 21 Jan 2026 | SPRB Spruce Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —5,000 at $0.00 | filing |
| 11 Dec 2025filed 21 Jan 2026 | SPRB Spruce Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,250 at $0.00 | filing |
| 11 Dec 2025filed 21 Jan 2026 | SPRB Spruce Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —5,000 at $0.00 | filing |
| 11 Dec 2025filed 21 Jan 2026 | SPRB Spruce Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,250 at $0.00 | filing |
| 11 Dec 2025filed 21 Jan 2026 | SPRB Spruce Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —266 | filing |
| 11 Dec 2025filed 21 Jan 2026 | SPRB Spruce Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code D | —266 | filing |
| 11 Dec 2025filed 21 Jan 2026 | SPRB Spruce Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —400 | filing |
| 11 Dec 2025filed 21 Jan 2026 | SPRB Spruce Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code D | —400 | filing |
| 11 Dec 2025filed 21 Jan 2026 | SPRB Spruce Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —266 | filing |
| 11 Dec 2025filed 21 Jan 2026 | SPRB Spruce Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code D | —266 | filing |
| 11 Dec 2025filed 21 Jan 2026 | SPRB Spruce Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —400 | filing |
| 11 Dec 2025filed 21 Jan 2026 | SPRB Spruce Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code D | —400 | filing |
| 11 Dec 2025filed 21 Jan 2026 | SPRB Spruce BiosciencesBiotechnology | SEC FORM 4 Code M | —1,250 at $0.00 | filing |
| 23 Jul 2025filed 24 Jul 2025 | SPRB Spruce Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 22 May 2024filed 24 May 2024 | SPRB Spruce Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 25 May 2023filed 26 May 2023 | SPRB Spruce Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 25 May 2022filed 27 May 2022 | SPRB Spruce Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,625 at $0.00 | filing |
| 23 Jun 2021filed 25 Jun 2021 | SPRB Spruce Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.